Evidence map›Paper›PMID 36732793›Full record

ArticleReproductive health2023

Women's perceptions of and experiences with the use of misoprostol for treatment of incomplete abortion in central Malawi: a mixed methods study.

Bertha Magreta Chakhame, Elisabeth Darj, Mphatso Mwapasa, Ursula Kalimembe Kafulafula, Alfred Maluwa, Jon Øyvind Odland, Maria Lisa Odland

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Reproductive health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Bertha Magreta ChakhameNorwegian University of Science and Technology, Trondheim, Norway. bchakhame@kuhes.ac.mw.
Elisabeth DarjNorwegian University of Science and Technology, Trondheim, Norway.
Mphatso MwapasaNorwegian University of Science and Technology, Trondheim, Norway.
Ursula Kalimembe KafulafulaKamuzu University of Health Sciences, Blantyre, Malawi.
Alfred MaluwaMalawi University of Science and Technology, Thyolo, Malawi.
Jon Øyvind OdlandNorwegian University of Science and Technology, Trondheim, Norway.
Maria Lisa OdlandNorwegian University of Science and Technology, Trondheim, Norway.
Kamuzu University of Health SciencesNorwegian University of Science and Technology · NOKamuzu Central Hospital · MWMalawi University of Science and Technology · MWNord University · NO

Funding

Helse Nord Norway (2020/39645)
6 · The paper itself

Abstract

backgroundAbortion-related complications are among the common causes of maternal mortality in Malawi. Misoprostol is recommended for the treatment of first-trimester incomplete abortions but is seldom used for post-abortion care in Malawi.

methodsA descriptive cross-sectional study that used mixed methods was conducted in three hospitals in central Malawi. A survey was done on 400 women and in-depth interviews with 24 women receiving misoprostol for incomplete abortion. Convenience and purposive sampling methods were used and data were analysed using STATA 16.0 for quantitative part and thematic analysis for qualitative part.

resultsFrom the qualitative data, three themes emerged around the following areas: experienced effects, support offered, and women's perceptions. Most women liked misoprostol and reported that the treatment was helpful and effective in expelling retained products of conception. Quantitative data revealed that the majority of participants, 376 (94%) were satisfied with the support received, and 361 (90.3%) believed that misoprostol was better than surgical treatment. The majority of the women 364 (91%) reported they would recommend misoprostol to friends.

conclusionsThe use of misoprostol for incomplete abortion in Malawi is acceptable and regarded as helpful and satisfactory among women.

Indexed as

Abortifacient Agents, NonsteroidalAbortion, IncompleteAbortion, InducedAbortion, SpontaneousMisoprostolCross-Sectional StudiesFemaleHumansMalawiPregnancyAbortifacient Agents, NonsteroidalMisoprostolFirst trimesterIncomplete abortionMisoprostolPost-abortion care

Identifiers

PMID36732793
PMCPMC9893686
OpenAlexW4319004558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.